title: Effectiveness of nafamostat mesilate on glomerulonephritis in immune-complex diseases.
authors.forename: T
authors.initials: T
authors.lastname: Miyata
authors.forename: Y
authors.initials: Y
authors.lastname: Fujita
authors.forename: R
authors.initials: R
authors.lastname: Inagi
authors.forename: I
authors.initials: I
authors.lastname: Inoue
authors.forename: S
authors.initials: S
authors.lastname: Sugiyama
authors.forename: K
authors.initials: K
authors.lastname: Maeda
mesh_terms: D001550:Benzamidines; D003169:Complement Inactivator Proteins / Q000627:therapeutic use*; D003449:Cryoglobulinemia / Q000150:complications; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007105:Immune Complex Diseases / Q000150:complications*; D008181:Lupus Nephritis / Q000188:drug therapy
chemical_list: D001550:Benzamidines; D003169:Complement Inactivator Proteins; D006146:Guanidines; C032855:nafamostat